Advances in HER2-targeted therapy: novel agents and opportunities beyond breast and gastric cancer

F Meric-Bernstam, AM Johnson, EEI Dumbrava… - Clinical Cancer …, 2019 - AACR
The introduction of HER2-targeted therapy for breast and gastric patients with ERBB2 (HER2)
amplification/overexpression has led to dramatic improvements in oncologic outcomes. In …

[PDF][PDF] Systematic functional annotation of somatic mutations in cancer

…, AM Johnson, J Zeng, CKM Ip, Z Ju, M Wester… - Cancer cell, 2018 - cell.com
The functional impact of the vast majority of cancer somatic mutations remains unknown,
representing a critical knowledge gap for implementing precision oncology. Here, we report the …

Highly parallel single-molecule identification of proteins in zeptomole-scale mixtures

…, AM Bardo, JL Bachman, J Marotta, AM Johnson… - Nature …, 2018 - nature.com
The identification and quantification of proteins lags behind DNA-sequencing methods in
scale, sensitivity, and dynamic range. Here, we show that sparse amino acid–sequence …

ALK: a tyrosine kinase target for cancer therapy

…, AM Bailey, AM Johnson… - Molecular …, 2017 - molecularcasestudies.cshlp.org
The anaplastic lymphoma kinase (ALK) gene plays an important physiologic role in the
development of the brain and can be oncogenically altered in several malignancies, including …

Two-component control of guest binding in a self-assembled cage molecule

P Liao, BW Langloss, AM Johnson… - Chemical …, 2010 - pubs.rsc.org
… Interestingly, even though the m-pyridine group can freely rotate and could be expected to
adopt a number of orientations, formation of polymers or other oligomers has not been observed …

[HTML][HTML] Eicosanoids in cancer: new roles in immunoregulation

AM Johnson, EK Kleczko, RA Nemenoff - Frontiers in pharmacology, 2020 - frontiersin.org
Eicosanoids represent a family of active biolipids derived from arachidonic acid primarily
through the action of cytosolic phospholipase A2-α. Three major downstream pathways have …

Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression

…, MV McSharry, TR Sippel, BL Bullock, AM Johnson… - Cancer research, 2018 - AACR
The complement cascade is a part of the innate immune system that acts primarily to remove
pathogens and injured cells. However, complement activation is also peculiarly associated …

Steric effects control self-sorting in self-assembled clusters

AM Johnson, RJ Hooley - Inorganic Chemistry, 2011 - ACS Publications
Endohedrally functionalized bis(pyridine) ligands show the ability to self-discriminate when
treated with coordinating metals to form self-assembled clusters. Self-sorting between …

Cancer cell–intrinsic expression of MHC class II regulates the immune microenvironment and response to anti–PD-1 therapy in lung adenocarcinoma

AM Johnson, BL Bullock, AJ Neuwelt… - The Journal of …, 2020 - journals.aai.org
MHC class II (MHCII) expression is usually restricted to APC but can be expressed by cancer
cells. We examined the effect of cancer cell–specific MHCII (csMHCII) expression in lung …

A supramolecular sorting hat: Stereocontrol in metal–ligand self‐assembly by complementary hydrogen bonding

MC Young, LR Holloway, AM Johnson… - Angewandte …, 2014 - Wiley Online Library
A combination of self‐complementary hydrogen bonding and metal–ligand interactions
allows stereocontrol in the self‐assembly of prochiral ligand scaffolds. A unique, non‐tetrahedral …